We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 795 results
  1. Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy

    The standard of treatment for node-positive endometrial cancer (FIGO Stage IIIC) in North America has been systemic therapy with or without...

    Elizabeth A. Tubridy, Neil K. Taunk, Emily M. Ko in Current Treatment Options in Oncology
    Article Open access 04 January 2024
  2. Endometriosis, a common but enigmatic disease with many faces: current concept of pathophysiology, and diagnostic strategy

    Endometriosis is a benign, common, but controversial disease due to its enigmatic etiopathogenesis and biological behavior. Recent studies suggest...

    Mayumi Takeuchi, Kenji Matsuzaki, Masafumi Harada in Japanese Journal of Radiology
    Article Open access 25 April 2024
  3. Ultrasound-guided transvaginal biopsies of pelvic lesions: diagnostic yield, safety profile, and technical considerations over a 20-year experience

    Purpose

    To evaluate diagnostic yield, safety profile, and specific technical considerations of transvaginal ultrasound (TVUS) guided biopsy/aspiration.

    ...
    Erika J. Wood, Perry J. Pickhardt, ... Meghan G. Lubner in Abdominal Radiology
    Article 24 January 2023
  4. Spontaneous Tumor Lysis Syndrome in a Case of Hepatocellular Carcinoma with Sarcomatoid Differentiation

    Sarcomatoid hepatocellular carcinoma is a rare histologic variant of primary liver cancer comprising of malignant spindle cells and typical...

    Raja Chhabra, Aditya Vidushi, ... Md Ali Osama in Indian Journal of Surgical Oncology
    Article 13 February 2024
  5. Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities

    Background

    Prostein (P501S), also termed solute carrier family 45 member 3 (SLC45A3) is an androgen regulated protein which is preferentially...

    Florian Viehweger, Carola Böcker, ... Simon Kind in Diagnostic Pathology
    Article Open access 13 January 2024
  6. Molecular and histopathology directed therapy for advanced bladder cancer

    Bladder cancer is a heterogeneous group of tumours with at least 40 histological subgroups. Patients with localized disease can be cured with...

    Constantine Alifrangis, Ursula McGovern, ... Mark Linch in Nature Reviews Urology
    Article 09 July 2019
  7. Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery

    Background

    Several studies have demonstrated that secondary cytoreductive surgery (SCS) for patients with recurrent uterine malignancies may improve...

    Chenyan Fang, Yingli Zhang, ... Tao Zhu in BMC Women's Health
    Article Open access 02 January 2024
  8. FIGO 2023 endometrial staging: a leap of faith into the new “prognostic based’ rather than “anatomical based” staging—too fast too furious??

    Background

    In 2023 FIGO revised the endometrial cancer staging system after 13 years. There is a lacuna of data regarding the performance and...

    Karthik Chandra Bassetty, Dimpy Begum, ... P. S. Roy in Journal of Cancer Research and Clinical Oncology
    Article Open access 11 May 2024
  9. A comparison of [18F]AlF- and 68Ga-labeled dual targeting heterodimer FAPI-RGD in malignant tumor: preclinical evaluation and pilot clinical PET/CT imaging

    Abstract

    Due to the heterogeneity of tumors, strategies to improve the effectiveness of dual-targeting tracers in tumor diagnostics have been...

    Nan Liu, Qiang Wan, ... Wei Zhang in European Journal of Nuclear Medicine and Molecular Imaging
    Article 22 January 2024
  10. The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review

    Purpose

    Selinexor is a novel XPO1 inhibitor which inhibits the export of tumor suppressor proteins and oncoprotein mRNAs, leading to cell-cycle arrest...

    Jennifer R. Landes, Stephen A. Moore, ... Stephen K. Tyring in Journal of Cancer Research and Clinical Oncology
    Article 08 August 2022
  11. SEOM-GEICO clinical guidelines on endometrial cancer (2021)

    Endometrial cancer (EC) is the second most common gynecological malignancy worldwide, the first in developed countries [Sung et al. in CA Cancer J...

    María Pilar Barretina-Ginesta, María Quindós, ... María Jesús Rubio-Pérez in Clinical and Translational Oncology
    Article Open access 21 March 2022
  12. Targeted Therapies in the Treatment of Uterine Serous Carcinoma

    Despite the dismal prognosis of uterine serous carcinoma (USC), recent advances in molecular classification and targeted treatments have demonstrated...

    Joan R. Tymon-Rosario, Megan Gorman, Alessandro D. Santin in Current Treatment Options in Oncology
    Article 30 November 2022
  13. Reclassifying tumour cell cycle activity in terms of its tissue of origin

    Genomic alterations resulting in loss of control over the cell cycle is a fundamental hallmark of human malignancies. Whilst pan-cancer studies have...

    Arian Lundberg, Joan Jong **g Yi, ... Nicholas P. Tobin in npj Precision Oncology
    Article Open access 20 August 2022
  14. Extrauterine Endometrial Stromal Sarcoma: A Case Report

    Extrauterine endometrial stromal sarcomas are rare malignancies, with 181 cases reported so far. The basic predisposing factor is endometriosis, and...

    S. Saikumar, Lakshmi Haridas, S. Renu in Indian Journal of Gynecologic Oncology
    Article 15 May 2023
  15. An analysis of the role of GAB2 in pan-cancer from a multidimensional perspective

    Background

    To explore the role of GAB2 in pan-cancer based on bioinformatics analysis.

    Methods

    Based on TCGA and GTEx databases, we used TIMER2.0...

    Yi Yin, Yong Li, ... Rui Ji in Discover Oncology
    Article Open access 12 July 2024
  16. Primary immature teratoma in the liver with growing teratoma syndrome and gliomatosis peritonei: a rare case report

    Background

    Primary liver immature teratoma is extremely rare and only 4 cases have been reported, let alone with growing teratoma syndrome (GTS)...

    RenMing Liu, JianNing Chen, ... Na Cheng in Diagnostic Pathology
    Article Open access 29 October 2022
  17. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors

    Fatty acid–binding proteins (FABPs) play a pivotal role in the metabolism of fatty acids and are expressed in a tissue-specific manner. FABP1 is most...

    David Dum, Ana Ocokoljic, ... Till Krech in Virchows Archiv
    Article Open access 11 August 2022
  18. SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer

    Purpose

    To provide a comprehensive overview and update of the Joint Société Internationale d’Urologie–International Consultation on Urological...

    Jeffrey J. Leow, Jens Bedke, ... Arnulf Stenzl in World Journal of Urology
    Article 23 January 2019
Did you find what you were looking for? Share feedback.